Scinai Immunotherapeuti Stock Forward View - Simple Moving Average
| SCNI Stock | USD 0.97 0.06 5.83% |
Scinai Stock outlook is based on your current time horizon. We recommend always using this module together with an analysis of Scinai Immunotherapeuti's historical fundamentals, such as revenue growth or operating cash flow patterns.
As of 29th of January 2026, the value of RSI of Scinai Immunotherapeuti's share price is approaching 48. This usually implies that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Scinai Immunotherapeuti, making its price go up or down. Momentum 48
Impartial
Oversold | Overbought |
Using Scinai Immunotherapeuti hype-based prediction, you can estimate the value of Scinai Immunotherapeutics from the perspective of Scinai Immunotherapeuti response to recently generated media hype and the effects of current headlines on its competitors.
The Simple Moving Average forecasted value of Scinai Immunotherapeutics on the next trading day is expected to be 1.00 with a mean absolute deviation of 0.06 and the sum of the absolute errors of 3.57. Scinai Immunotherapeuti after-hype prediction price | USD 0.97 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Scinai Immunotherapeuti to cross-verify your projections. Scinai Immunotherapeuti Additional Predictive Modules
Most predictive techniques to examine Scinai price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Scinai using various technical indicators. When you analyze Scinai charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Scinai Immunotherapeuti Simple Moving Average Price Forecast For the 30th of January
Given 90 days horizon, the Simple Moving Average forecasted value of Scinai Immunotherapeutics on the next trading day is expected to be 1.00 with a mean absolute deviation of 0.06, mean absolute percentage error of 0.01, and the sum of the absolute errors of 3.57.Please note that although there have been many attempts to predict Scinai Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Scinai Immunotherapeuti's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Scinai Immunotherapeuti Stock Forecast Pattern
| Backtest Scinai Immunotherapeuti | Scinai Immunotherapeuti Price Prediction | Buy or Sell Advice |
Scinai Immunotherapeuti Forecasted Value
In the context of forecasting Scinai Immunotherapeuti's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Scinai Immunotherapeuti's downside and upside margins for the forecasting period are 0.01 and 8.47, respectively. We have considered Scinai Immunotherapeuti's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Moving Average forecasting method's relative quality and the estimations of the prediction error of Scinai Immunotherapeuti stock data series using in forecasting. Note that when a statistical model is used to represent Scinai Immunotherapeuti stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 109.525 |
| Bias | Arithmetic mean of the errors | 0.0082 |
| MAD | Mean absolute deviation | 0.0604 |
| MAPE | Mean absolute percentage error | 0.0646 |
| SAE | Sum of the absolute errors | 3.565 |
Predictive Modules for Scinai Immunotherapeuti
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Scinai Immunotherapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Scinai Immunotherapeuti After-Hype Price Density Analysis
As far as predicting the price of Scinai Immunotherapeuti at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Scinai Immunotherapeuti or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Scinai Immunotherapeuti, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Scinai Immunotherapeuti Estimiated After-Hype Price Volatility
In the context of predicting Scinai Immunotherapeuti's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Scinai Immunotherapeuti's historical news coverage. Scinai Immunotherapeuti's after-hype downside and upside margins for the prediction period are 0.05 and 8.44, respectively. We have considered Scinai Immunotherapeuti's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Scinai Immunotherapeuti is abnormally volatile at this time. Analysis and calculation of next after-hype price of Scinai Immunotherapeutics is based on 3 months time horizon.
Scinai Immunotherapeuti Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Scinai Immunotherapeuti is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Scinai Immunotherapeuti backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Scinai Immunotherapeuti, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.32 | 7.47 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | Within a week |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
0.97 | 0.97 | 0.00 |
|
Scinai Immunotherapeuti Hype Timeline
Scinai Immunotherapeutics is at this time traded for 0.97. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Scinai is estimated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is estimated to be very small, whereas the daily expected return is at this time at -0.32%. %. The volatility of related hype on Scinai Immunotherapeuti is about 0.0%, with the expected price after the next announcement by competition of 0.97. The company has price-to-book ratio of 1.56. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Scinai Immunotherapeutics had not issued any dividends in recent years. The entity had 1:10 split on the 21st of May 2024. Given the investment horizon of 90 days the next estimated press release will be within a week. Check out Historical Fundamental Analysis of Scinai Immunotherapeuti to cross-verify your projections.Scinai Immunotherapeuti Related Hype Analysis
Having access to credible news sources related to Scinai Immunotherapeuti's direct competition is more important than ever and may enhance your ability to predict Scinai Immunotherapeuti's future price movements. Getting to know how Scinai Immunotherapeuti's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Scinai Immunotherapeuti may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| ONCO | Onconetix | 0.00 | 0 per month | 0.00 | (0.18) | 9.09 | (12.46) | 36.81 | |
| SPRC | Scisparc | 0.00 | 0 per month | 0.00 | (0.39) | 3.57 | (12.20) | 30.69 | |
| AZTR | Azitra Inc | 0.00 | 0 per month | 0.00 | (0.16) | 6.90 | (10.53) | 34.09 | |
| INDP | Indaptus Therapeutics | 0.00 | 0 per month | 0.00 | (0.04) | 13.58 | (12.56) | 51.64 | |
| SLXN | Biomotion Sciences Ordinary | 0.00 | 0 per month | 0.00 | (0.10) | 15.09 | (8.19) | 37.24 | |
| SLRX | Salarius Pharmaceuticals | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| JSPR | Jasper Therapeutics | 0.00 | 0 per month | 0.00 | (0.09) | 7.73 | (9.04) | 31.75 | |
| REVB | Revelation Biosciences | 0.00 | 0 per month | 0.00 | (0.27) | 5.56 | (9.09) | 35.57 | |
| PBM | Psyence Biomedical Ltd | 0.00 | 0 per month | 0.00 | (0.23) | 9.41 | (13.79) | 96.66 | |
| ENVB | Enveric Biosciences | 0.00 | 0 per month | 0.00 | (0.01) | 14.08 | (16.57) | 121.83 |
Other Forecasting Options for Scinai Immunotherapeuti
For every potential investor in Scinai, whether a beginner or expert, Scinai Immunotherapeuti's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Scinai Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Scinai. Basic forecasting techniques help filter out the noise by identifying Scinai Immunotherapeuti's price trends.Scinai Immunotherapeuti Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Scinai Immunotherapeuti stock to make a market-neutral strategy. Peer analysis of Scinai Immunotherapeuti could also be used in its relative valuation, which is a method of valuing Scinai Immunotherapeuti by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Scinai Immunotherapeuti Market Strength Events
Market strength indicators help investors to evaluate how Scinai Immunotherapeuti stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Scinai Immunotherapeuti shares will generate the highest return on investment. By undertsting and applying Scinai Immunotherapeuti stock market strength indicators, traders can identify Scinai Immunotherapeutics entry and exit signals to maximize returns.
Scinai Immunotherapeuti Risk Indicators
The analysis of Scinai Immunotherapeuti's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Scinai Immunotherapeuti's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting scinai stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 5.41 | |||
| Standard Deviation | 7.47 | |||
| Variance | 55.85 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Scinai Immunotherapeuti
The number of cover stories for Scinai Immunotherapeuti depends on current market conditions and Scinai Immunotherapeuti's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Scinai Immunotherapeuti is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Scinai Immunotherapeuti's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Scinai Immunotherapeuti Short Properties
Scinai Immunotherapeuti's future price predictability will typically decrease when Scinai Immunotherapeuti's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Scinai Immunotherapeutics often depends not only on the future outlook of the potential Scinai Immunotherapeuti's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Scinai Immunotherapeuti's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 806.4 K | |
| Cash And Short Term Investments | 2 M |
Check out Historical Fundamental Analysis of Scinai Immunotherapeuti to cross-verify your projections. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Is there potential for Stock market expansion? Will Scinai introduce new products? Factors like these will boost the valuation of Scinai Immunotherapeuti. If investors know Scinai will grow in the future, the company's valuation will be higher. Understanding fair value requires weighing current performance against future potential. All the valuation information about Scinai Immunotherapeuti listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Understanding Scinai Immunotherapeutics requires distinguishing between market price and book value, where the latter reflects Scinai's accounting equity. The concept of intrinsic value—what Scinai Immunotherapeuti's is actually worth based on fundamentals—guides informed investors toward better entry and exit points. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Market sentiment, economic cycles, and investor behavior can push Scinai Immunotherapeuti's price substantially above or below its fundamental value.
Please note, there is a significant difference between Scinai Immunotherapeuti's value and its price as these two are different measures arrived at by different means. Investors typically determine if Scinai Immunotherapeuti is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Scinai Immunotherapeuti's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.